Wai Yuen Tong Medicine Holdings (HKSE:00897) EV-to-EBITDA : 8.81 (As of Jun. 01, 2024)

Wai Yuen Tong Medicine Holdings EV-to-EBITDA Chart

Wai Yuen Tong Medicine Holdings Annual Data
	Trend	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
EV-to-EBITDA		Get a 7-Day Free Trial					0.19	4.49	-25.26	17.31	12.13

Wai Yuen Tong Medicine Holdings Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EV-to-EBITDA	Get a 7-Day Free Trial															-	17.31	-	12.13	-

Competitive Comparison of Wai Yuen Tong Medicine Holdings's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Wai Yuen Tong Medicine Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wai Yuen Tong Medicine Holdings's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wai Yuen Tong Medicine Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Wai Yuen Tong Medicine Holdings's EV-to-EBITDA falls into.

Wai Yuen Tong Medicine Holdings EV-to-EBITDA Calculation

Wai Yuen Tong Medicine Holdings's EV-to-EBITDA for today is calculated as:

Wai Yuen Tong Medicine Holdings's current Enterprise Value is HK$1,384 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Wai Yuen Tong Medicine Holdings's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was HK$157 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wai Yuen Tong Medicine Holdings  (HKSE:00897) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Wai Yuen Tong Medicine Holdings's PE Ratio for today is calculated as:

Wai Yuen Tong Medicine Holdings's share price for today is HK$0.224.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Wai Yuen Tong Medicine Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was HK$0.030.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Wai Yuen Tong Medicine Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Wai Yuen Tong Medicine Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Wai Yuen Tong Medicine Holdings (HKSE:00897) Business Description